Jean-Luc Perfettini

5PUBLICATIONS
18CO-AUTHORS
Haematological tumoursTumour immunologyNeural engineeringCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 04, 2023
In vivo reduction of RAD51-mediated homologous recombination triggers aging but impairs oncogenesis.

Gabriel Matos-Rodrigues, Vilma Barroca, Ali-Akbar Muhammad

|Nov 08, 2022
CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

Awatef Allouch, Laurent Voisin, Yanyan Zhang

|Jun 10, 2020
SUGT1 controls susceptibility to HIV-1 infection by stabilizing microtubule plus-ends.

Awatef Allouch, Cristina Di Primio, Audrey Paoletti

|Jun 20, 2018
Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death.

Isabelle Martins, Syed Qasim Raza, Laurent Voisin

|Feb 07, 2018
Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas.

Olivier Zajac, Joel Raingeaud, Fotine Libanje

Pageof 1

Frequent Collaborators

1 joint publications

Patrick Gonin

1 joint publications

Salima Benbarche

1 joint publications

Camille Lobry

1 joint publications

Fanny Jaulin